Profile data is unavailable for this security.
About the company
Arch Therapeutics, Inc. is a biotechnology company developing and marketing products based on its AC5 self-assembling technology platform. These products can be advances in the field of stasis and barrier applications. The Company’s flagship products and product candidates are derived from its AC5 self-assembling peptide (SAP) technology platform and referred to as AC5 or the AC5 Devices. These include AC5 Advanced Wound System and AC5 Topical Hemostat, which are intended for skin applications, such as management of complicated chronic wounds and acute surgical wounds. Other products are in development for use in minimally invasive or open surgical procedures and include AC5-GTM for gastrointestinal endoscopic procedures and AC5-V and AC5 Surgical Hemostat for hemostasis inside the body. It is developing BioSurgery products for internal use, including for hemostasis and sealant applications, and gastrointestinal endoscopic surgical procedures.
- Revenue in USD (TTM)148.17k
- Net income in USD-12.99m
- Incorporated2009
- Employees8.00
- LocationArch Therapeutics Inc235 Walnut Street, Suite 6FRAMINGHAM 01702United StatesUSA
- Phone+1 (617) 431-2313
- Websitehttps://www.archtherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sonendo Inc | 37.46m | -47.49m | 677.24k | 216.00 | -- | 0.033 | -- | 0.0181 | -100.33 | -88.72 | 79.04 | 49.07 | 0.498 | 1.95 | 6.91 | 173,421.30 | -63.14 | -- | -78.26 | -- | 35.04 | -- | -126.79 | -- | 1.73 | -8.54 | 0.5194 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
Dynatronics Corp | 32.53m | -3.43m | 870.67k | 111.00 | -- | 0.1031 | -- | 0.0268 | -0.7237 | -0.7237 | 6.86 | 2.67 | 1.16 | 3.83 | 9.08 | 293,098.80 | -9.63 | -7.48 | -13.37 | -10.07 | 23.47 | 25.81 | -8.29 | -5.98 | 0.6442 | -5.44 | 0.2139 | -- | -19.89 | -12.26 | 39.47 | -- | 1.66 | -- |
Nano Mobile Healthcare Inc | 0.00 | -5.46m | 982.13k | 3.00 | -- | -- | -- | -- | -0.2255 | -0.2255 | 0.00 | -0.0129 | 0.00 | -- | -- | 0.00 | -10,475.82 | -- | -- | -- | -- | -- | -- | -- | -- | -0.3173 | -- | -- | -- | -- | -- | -- | -- | -- |
Remedent Inc | 1.13m | -259.38k | 999.80k | 16.00 | -- | 0.2112 | -- | 0.8857 | -0.013 | -0.013 | 0.0565 | 0.2367 | 0.1474 | 3.45 | 2.69 | -- | -3.24 | 7.35 | -5.20 | 12.93 | 65.38 | 64.60 | -21.97 | 21.20 | 0.2033 | -0.772 | 0.00 | -- | -33.63 | -21.70 | -140.31 | -- | -- | -- |
LogicMark Inc | 9.74m | -15.46m | 1.08m | 26.00 | -- | 0.0406 | -- | 0.1112 | -8.62 | -8.62 | 5.21 | 5.37 | 0.4993 | 3.87 | 687.63 | 374,625.80 | -72.96 | -28.39 | -78.79 | -33.18 | 66.93 | 67.24 | -146.12 | -63.55 | 2.36 | -- | 0.00 | -- | -16.67 | -10.32 | -117.56 | -- | 37.76 | -- |
Escalon Medical Corp | 11.98m | -176.93k | 1.11m | 40.00 | -- | 0.9551 | -- | 0.0928 | -0.0239 | -0.0239 | 1.62 | 0.244 | 2.38 | 4.27 | 6.34 | 299,537.80 | -2.49 | -1.31 | -5.51 | -2.88 | 42.95 | 43.60 | -1.05 | -0.6443 | 1.04 | -5.03 | 0.1457 | -- | -1.63 | 4.47 | -179.87 | -- | 12.74 | -- |
Catheter Precision Inc | 436.00k | -9.49m | 1.22m | 14.00 | -- | 0.023 | -- | 2.80 | -12.95 | -12.95 | 0.6046 | 18.90 | 0.0141 | 0.5574 | 3.89 | 31,142.86 | -30.71 | -- | -33.63 | -- | 92.20 | -- | -2,176.84 | -- | 0.098 | -- | 0.0434 | -- | 3,057.14 | -- | -165.67 | -- | -- | -- |
Arch Therapeutics Inc | 148.17k | -12.99m | 1.25m | 8.00 | -- | -- | -- | 8.46 | -3.69 | -3.69 | 0.0383 | -2.83 | 0.10 | 0.0662 | -- | 18,521.25 | -828.03 | -188.28 | -- | -804.63 | 39.58 | -- | -8,276.08 | -26,945.92 | 0.0051 | -1.32 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
Hawkeye Systems Inc | 0.00 | -578.72k | 1.37m | 44.00 | -- | -- | -- | -- | -0.093 | -0.093 | 0.00 | -0.3006 | 0.00 | -- | -- | -- | -117.01 | -314.04 | -- | -- | -- | -- | -- | -195.39 | -- | -1.49 | -- | -- | -- | -- | 52.81 | -- | -- | -- |
Telesis Bio Inc | 16.28m | -50.12m | 1.62m | 137.00 | -- | -- | -- | 0.0993 | -29.66 | -30.68 | 9.61 | 5.61 | 0.1947 | 3.15 | 3.40 | 118,832.10 | -57.15 | -- | -64.21 | -- | 49.47 | -- | -293.54 | -- | 1.72 | -52.96 | 0.356 | -- | 0.2697 | -- | -1.14 | -- | -- | -- |
Acutus Medical Inc | 12.16m | -5.82m | 1.64m | 233.00 | -- | -- | -- | 0.1347 | -0.1965 | 0.6966 | 0.413 | -0.1639 | 0.1791 | 1.32 | 1.44 | 52,184.55 | -8.58 | -46.76 | -11.07 | -56.88 | -13.40 | -89.12 | -47.89 | -773.49 | 1.88 | -3.39 | 1.18 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
SINTX Technologies Inc | 3.13m | -8.60m | 1.77m | 43.00 | -- | 0.2005 | -- | 0.5666 | -271.52 | -271.52 | 16.44 | 11.82 | 0.1818 | 1.77 | 7.63 | 72,697.67 | -50.01 | -45.71 | -62.67 | -57.36 | 67.72 | 58.47 | -275.14 | -681.80 | 1.79 | -- | 0.0265 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
Helius Medical Technologies Inc | 594.00k | -8.84m | 1.77m | 22.00 | -- | 0.2797 | -- | 2.98 | -10.68 | -10.68 | 0.5042 | 1.98 | 0.0606 | 0.7486 | 4.48 | 27,000.00 | -90.17 | -98.37 | -110.33 | -143.57 | 12.79 | 37.27 | -1,487.54 | -1,580.66 | 3.80 | -- | 0.00 | -- | -18.17 | 6.14 | 37.11 | -- | -41.95 | -- |
Holder | Shares | % Held |
---|---|---|
Cavalry Fund I Management LLCas of 18 Jul 2023 | 300.00k | 6.75% |